HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
ProPhase Labs, Inc. (PRPH)
5.66  -0.26  (-4.39%) 06-21 03:34
Open: 5.9 High: 5.9
Pre.close: 5.92 Low: 5.5093
Volume: 191,525 Ave vol: 438,631
52w High: 16.04 52w Low: 1.2
MA(50): 5.599 MA(200): 8.04
EPS: -0.021 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Website: http://www.prophaselabs.com
Market Cap (M): 86
Shares Out (M): 15
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer consumer healthcare products and dietary supplements. The company is headquartered in Doylestown, Pennsylvania and currently employs 54 full-time employees. The firm is engaged in the research and development of over-the-counter (OTC) drugs and natural base health products, including supplements, personal care and cosmeceutical products. The firm's products include TK Supplements and ORXx Complete. TK Supplements consists of LEGENDZ XL, a male sexual enhancement; TRIPLE EDGE XL, a daily energy and stamina booster, and SUPER PROSTAFLOW plus, a supplement to support prostate and urinary health. The firm's OTC offerings include the ORXx cough/cold drops. Its consumer health customers include national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies.
Technical analysis
Overall: Underperform
MA: Bearish MACD: Bullish
KDJ: Bearish RSI: Bearish
Target 1: 7.03 Target 2: 8.16
Resist 1: 6.02 Resist 2: 6.99
Support 1: 4.44 Support 2: 3.69
Company key metrics
Revenue per Share: 1.2517
Net Income per Share: -0.1833
Cash per Share: 0.0007
Book Value per Share: 0.0009
Price to Sales: 8.0847
Price to Book Value: 11116.0856
Earnings Yield: -0.0181
Dividend Yield: 0
Debt to Equity: -0.2617
Debt to Assets: 0.6639
Financial analysis
Price to Book Value: Outperform
Return on Assets: Neutral
Return on Equity: Neutral
Discounted cash flow: Outperform
Price to Earnings: Outperform
Debt to Equity: Outperform
Stock Charts

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.